docketcity.com
2024 ACT-233

Request for Waiver of Bid - Emergency Management - 3 MG Nasal RiVive (Nasal Naloxone) (Remedy Alliance Inc)

Action Item Passed Introduced November 6, 2024
Committee
Personnel & Finance Committee
Requested by
Administration
Introduced
November 6, 2024
Passed
November 18, 2024

Where it was heard

Personnel & Finance Committee Nov 18, 2024 approved Pass